61 results
Page 3 of 4
6-K
EX-99.1
jmj z2wugy
31 Aug 21
Index to the Unaudited Interim Condensed Consolidated Financial Statements
4:16pm
6-K
EX-99.3
3q5cwwajhyj zn
31 Aug 21
Index to the Unaudited Interim Condensed Consolidated Financial Statements
4:16pm
6-K
EX-99.2
gzbikbb
3 Jun 21
Development program exploring the potential of CBP-174 in the treatment of chronic inflammatory pruritus
6:04am
6-K
EX-99.1
1wbk0veemy8 lkf
3 Jun 21
Development program exploring the potential of CBP-174 in the treatment of chronic inflammatory pruritus
6:04am
6-K
r5jewzqoo
3 Jun 21
Development program exploring the potential of CBP-174 in the treatment of chronic inflammatory pruritus
6:04am
6-K
EX-99.1
zcl0sv 63mwo
17 May 21
Connect Biopharma Announces First
5:27pm
424B4
vrijor
19 Mar 21
Prospectus supplement with pricing info
4:49pm
F-1/A
uoycrjquwdlw27v8 ka
18 Mar 21
Registration statement (foreign) (amended)
6:15am
F-1/A
qcqr0
12 Mar 21
Registration statement (foreign) (amended)
5:02pm
F-1/A
EX-99.1
suws7e
12 Mar 21
Registration statement (foreign) (amended)
5:02pm
F-1
EX-10.13
go6rt8265up r6ruut
26 Feb 21
Registration statement (foreign)
4:56pm
F-1
EX-10.15
idlgs4oct z54ym
26 Feb 21
Registration statement (foreign)
4:56pm
F-1
EX-10.9
e3tc3r9
26 Feb 21
Registration statement (foreign)
4:56pm
F-1
5vq9ubo
26 Feb 21
Registration statement (foreign)
4:56pm
F-1
EX-10.10
bchbrd cs6m2
26 Feb 21
Registration statement (foreign)
4:56pm
DRSLTR
v2zre ixr
26 Jan 21
Correspondence regarding draft registration statement
12:00am
DRS/A
br3i1c54z6448xfw
26 Jan 21
Draft registration statement (amended)
12:00am
UPLOAD
iimfczc0
13 Jan 21
Letter from SEC
12:00am
DRS
EX-10.7
v2y85f8n 4pcu52j
17 Dec 20
Draft registration statement
12:00am
DRS
EX-10.6
xmm9ztqy0hg 4myumxp0
17 Dec 20
Draft registration statement
12:00am